Randox at EuroMedLab 2019 EduW 21

Event Information

Share this event

Date and Time

Event description
EduW 21 | Novel Multiplex Molecular Diagnostics: A Cross-Platform Comparison| Room 117

About this Event

Recent advances in multiplex molecular testing, such as those used by Randox have facilitated syndromic screening of clinical specimens from a single patient sample. Implementation of molecular multiplexing allows rapid, comprehensive patient assessment, which can inform patient care pathways and, by identifying specific causal agents of infection, allow tailored (or no) medical intervention. Randox will discuss the launch of two new molecular platforms in 2019, which will enable fully automated diagnostics of up to 44 different pathogens from a single patient sample.

Date and Time

Save This Event

Event Saved